Sathish Vemula

pharmaceutical warning letters 483s news new guidelines guidance fda warning letter 483's non compliance reports audit findings gmp regulatory newsletter fda regulations news uptoday new guidance new mapp release audit analytical eu non compliance reports updates data integrity hplc error laboratory buildings and facilities 21 cfr 211.42 ema non compliance reports who noc 21 cfr 211.165 pharmaceutical news 21 cfr 211.100; gmp; new 21 cfr 211.67 chromatography data system (cds) in pharma investigations batch record review 21 cfr 211.192 detecting and preventing issues 21 cfr 211.22 21 cfr 211.160 december 2014 quality control glp summary october 2014 pharma septemer 2014 news 483 uk guest of the month dr. m damodharan - vice pre bulgaria - scm pharma limited india - vetprom ad solid dosage processing all about tablets (pharma) tablet manufacturing process introduction processing problems unit operations excipients oos investigating aberrant potency values in pharma an aberrant investigation - introduction - roles & responsibilities- reaso sample preparation techniques of solid dosage form hplc or gc chromatography - apextrack integration regulations of july 2014 audit observations pharma noc regulation of the month pharma june 2014 news uptoday new guidelines audit findings guest o findings guidelines audit pharmaceutical industry waters chromatography